FDA Approves First Generic of Once-Daily GLP-1 Injection to …
Español. Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) …
GLP-1 RAs efficacious for weight loss in overweight, obesity …
2 days ago · For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published …
Research shows GLP-1 drugs are effective but complex - UChicago …
May 30, 2024 · While experts caution against overusing GLP-1RAs or viewing them as a universal cure-all for obesity, physicians and researchers agree that the drugs are highly effective for …
FDA clarifies policies for compounders as national GLP-1 supply …
Oct 22, 2024 · The U.S. Food and Drug Administration has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 (GLP-1) medication, has been resolved.
Science’s Breakthrough of the Year: GLP-1 agonists can blunt …
Dec 15, 2023 · Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year's discovery that these drugs can blunt obesity-associated health problems as its …
New hope for binge eating and bulimia: GLP-1 drugs could be the …
Mar 4, 2024 · Glucagon-like peptide-1 (GLP-1) is a hormone and neuropeptide produced in the intestine and brain. This hormone inhibits appetite, reduces food intake, reduces body weight, …
Glucagon-like peptide-1 receptor: mechanisms and advances in …
Sep 18, 2024 · We introduce recent studies that demonstrate the remarkable performance of GLP-1RAs in slowing the progression of neurodegenerative diseases, reducing inflammation, …
Novel GLP-1 receptor agonists offer hope for long-lasting …
Oct 22, 2023 · In a study published in Scientific Reports, researchers engineer and computationally analyze three chimeric agonists of the glucagon -like peptide-1 (GLP-1) …
GLP-1 agonists: US sees 700% increase over four years in ... - The BMJ
Jul 23, 2024 · The number of patients without diabetes but with overweight or obesity who started glucagon like peptide-1 receptor agonist (GLP-1RA) treatment in the US has risen from around …
GLP-1 Drug Liraglutide May Protect Against Dementia
PHILADELPHIA, July 30, 2024 — A glucagon-like peptide-1 (GLP-1) drug appears to slow cognitive decline by protecting the brain, according to Phase 2b clinical trial data reported …